Transient Efficacy of Tofacitinib in Alopecia Areata Universalis

Case Reports in Dermatology

Volumn 8, Issue 1, 2016, Pages 102-106

  Anzengruber, Florian ^a   Maul, Julia Tatjana ^a   Kamarachev, Jivko ^a   Trüeb, Ralph M ^b   French, Lars E ^a   Navarini, Alexander A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Dermatologische Praxis and Haarcenter   (Switzerland)

Author keywords

Alopecia areata universalis; Janus kinase inhibitors; Tofacitinib

Indexed keywords

AZATHIOPRINE; DIPHENCYPRONE; INFLIXIMAB; METHOTREXATE; PREDNISOLONE; RUXOLITINIB; STEROID; TOFACITINIB;

ADULT; ALOPECIA AREATA; ALOPECIA AREATA UNIVERSALIS; ARTICLE; CASE REPORT; COMPASSIONATE USE; CONSULTATION; CORTICOSTEROID THERAPY; DISEASE COURSE; HAIR GROWTH; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MEDICAL HISTORY; MIDDLE AGED; PRIORITY JOURNAL; RETINA VASCULITIS; SCALP; SKIN BIOPSY; SKIN EXAMINATION; TOPICAL TREATMENT; UVEITIS;

EID: 84964200244     PISSN: None     EISSN: 16626567     Source Type: Journal    
DOI: 10.1159/000445182     Document Type: Article

References (24)

1. Hon KL, Leung AK: Alopecia areata. Recent Pat Inflamm Allergy Drug Discov 2011;5:98-107.
2. Jabbari A, et al: Genetic basis of alopecia areata: a roadmap for translational research. Dermatol Clin 2013;31:109-117.
3. Madani S, Shapiro J: Alopecia areata update. J Am Acad Dermatol 2000;42:549-566; quiz 567-570.
4. Ghanizadeh A, Ayoobzadehshirazi A: A review of psychiatric disorders comorbidities in patients with alopecia areata. Int J Trichology 2014;6:2-4.
5. Hordinsky MK: Overview of alopecia areata. J Investig Dermatol Symp Proc 2013;16:S13-S15.
6. Petukhova L, et al: Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010;466:113-117.
7. Jackow C, et al: Alopecia areata and cytomegalovirus infection in twins: genes versus environment? J Am Acad Dermatol 1998;38:418-425.
8. Rodriguez TA, et al: Concordance rate of alopecia areata in identical twins supports both genetic and environmental factors. J Am Acad Dermatol 2010;62:525-527.
9. Blaumeiser B, et al: Familial aggregation of alopecia areata. J Am Acad Dermatol 2006;54:627-632.
10. McDonagh AJ, Tazi-Ahnini R: Epidemiology and genetics of alopecia areata. Clin Exp Dermatol 2002;27:405-409.
11. van der Steen P, et al: The genetic risk for alopecia areata in first degree relatives of severely affected patients. An estimate. Acta Derm Venereol 1992;72:373-375.
12. Gilhar A, Paus R, Kalish RS: Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest 2007;117:2019-2027.
13. Delamere FM, et al: Interventions for alopecia areata. Cochrane Database Syst Rev 2008:CD004413.
14. Suarez-Farinas M, et al: Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing. J Allergy Clin Immunol 2015;136:1277-1287.
15. Verros C, Rallis E, Crowe M: Letter: Alopecia areata during ustekinumab administration: co-existence or an adverse reaction? Dermatol Online J 2012;18:14.
16. Tauber M, et al: Alopecia areata developing during ustekinumab therapy: report of two cases. Eur J Dermatol 2013;23:912-913.
17. Slowinska M, et al: Alopecia areata developing paralell to improvement of psoriasis during ustekinumab therapy. J Dermatol Case Rep 2010;4:15-17.
18. Andrisani G, et al: Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab. Eur Rev Med Pharmacol Sci 2013;17:2831-2836.
19. Tillack C, et al: Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-gamma-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment. Gut 2014;63:567-577.
20. Xing L, et al: Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat Med 2014;20:1043-1049.
21. Craiglow BG, King BA: Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis. J Invest Dermatol 2014;134:2988-2990.
22. Pan F, et al: Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science 2009;325:1142-1146.
23. McDonagh AJ, Messenger AG: The pathogenesis of alopecia areata. Dermatol Clin 1996;14:661-670.
24. Tobin DJ, et al: Antibodies to hair follicles in alopecia areata. J Invest Dermatol 1994;102:721-724.